Related Experiment Videos
Adverse dermatologic effects of cardiovascular drug therapy: part III
William H Frishman1, Brian D Brosnan, Marc Grossman
1Department of Medicine, New York Medical College, Valhalla, USA.
Insights
Cardiovascular drugs, while beneficial, can cause skin reactions. This review details adverse dermatologic responses to common cardiovascular medications, including antihypertensives and lipid-lowering agents.
Area of Science:
- Dermatology
- Cardiology
- Pharmacology
Background:
- Cardiovascular disease (CVD) prevalence increases with age.
- Pharmacologic therapies are crucial for managing CVD.
- Adverse drug reactions, including dermatologic responses, can occur.
Purpose of the Study:
- To review cutaneous reaction patterns associated with cardiovascular drugs.
- To provide a comprehensive overview of drug-induced skin conditions in CVD patients.
Main Methods:
- Literature review of adverse dermatologic responses.
- Categorization of reactions based on drug classes: vasodilators, antihypertensives, anticoagulants, antiplatelet agents, thrombolytics, and lipid-lowering agents.
Main Results:
- Cardiovascular medications can manifest a wide spectrum of dermatologic side effects.
- Specific reaction patterns are linked to different drug classes used in CVD management.
Conclusions:
- Awareness of potential skin reactions is essential for clinicians treating cardiovascular disease.
- Understanding these adverse events aids in patient management and therapeutic adjustments.
Abstract:
Cardiovascular disease is common, affecting an increasing number of persons as the population ages. To combat this growing health problem, physicians use a multitude of medications in the treatment of their patients. Although pharmacologic therapy greatly enhances quality of life for a majority of patients, there is always the potential for an unfavorable reaction. For example, cardiovascular drugs can induce a vast array of adverse dermatologic responses. This article reviews the various cutaneous reaction patterns that can occur as a result of treatment with vasodilators and other antihypertensive drugs, anticoagulants and antiplatelet drugs, thrombolytic agents, and lipid-lowering agents.